Intercept

Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) continued to sell off Friday in reaction to the U.S. Food and Drug Administration's letter to physicians warning them against the company's liver disease medicine called Ocaliva.
One of the main takeaways from the FDA's letter is the absence of...

The U.S. Food and Drug Administration sent a letter to doctors highlighting potential negative side effects from Intercept Pharmaceuticals Inc (NASDAQ: ICPT)'s liver disease medicine called Ocaliva.
The FDA said in its letter that if it is incorrectly dosed in patients with moderate to severe...

Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) plummeted to a new 52-week low of $90.53 Tuesday morning before recovering a few dollars per share in reaction to a warning letter from the company to physicians. The letter cautioned against overdosing certain patients suffering from primary...

Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) jumped nearly 10 percent early Friday morning after the company provided an update on an ongoing clinical trial.
Intercept is a biopharmaceutical company that focuses on developing and commercializing therapeutics to treat progressive non-viral...

U.S. stocks rose as earning season unofficially kicked off with Citigroup reporting better than expected earnings.
The Dow Jones Industrial average set new intra-day records, hitting an all time high of 17,088.43 as investors appear to be comfortable with holding blue chips instead of...

U.S. stocks were little changed as investors digested comments coming from head of the Federal Reserve Bank of St. Louis.
The Fed's Jim Bullard said that the 2.9 percent decline in the first quarter GDP is “giving me heartburn.” Bullard added that the worse than expected figure...

U.S. stocks declined for the second straight day after investors and traders digested disappointing earnings from retailers and economic reports were disappointing.
The Dow suffered a triple-digit point loss and declined one percent after the retailer giant Wal-Mart failed to "wow" investors....

U.S. stocks rose as investors focused on positive economic data rather than the tense situation in Ukraine.
Economic reports showed that U.S. industrial production rose in February.
President Obama imposed sanctions against Russian and Crimea officials following an election on Sunday which...